Francisco J Salguero Selected Research

Latent Infection

1/2018

Experimental infection of cattle with Mycobacterium tuberculosis isolates shows the attenuation of the human tubercle bacillus for cattle.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francisco J Salguero Research Topics

Disease

28	Infections 06/2022 - 05/2004
9	COVID-19 01/2022 - 10/2020
6	Tuberculosis (Tuberculoses) 01/2021 - 07/2011
6	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2021 - 07/2009
4	Human Influenza (Influenza) 01/2022 - 01/2018
4	Prion Diseases (Transmissible Spongiform Encephalopathies) 11/2006 - 01/2004
3	Melioidosis 12/2017 - 07/2011
2	Coinfection 08/2021 - 01/2021
2	Granuloma 01/2021 - 07/2011
2	Weight Loss (Weight Reduction) 01/2021 - 01/2020
2	Necrosis 01/2019 - 02/2013
2	Neoplasms (Cancer) 01/2018 - 10/2013
2	Hepatitis 10/2015 - 04/2013
2	Bovine Spongiform Encephalopathy (Mad Cow Disease) 01/2006 - 05/2004
1	Pneumonia (Pneumonitis) 01/2021
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021
1	Severe Acute Respiratory Syndrome 01/2021
1	Disease Progression 01/2021
1	Bovine Tuberculosis 01/2021
1	Hantavirus Infections 10/2020
1	Critical Illness (Critically Ill) 10/2019
1	Latent Infection 01/2018
1	Cognitive Dysfunction 01/2018
1	Carcinogenesis 01/2018
1	Non-alcoholic Fatty Liver Disease 01/2018
1	Orthomyxoviridae Infections 10/2016
1	Edema (Dropsy) 10/2015
1	Fibrosis (Cirrhosis) 10/2015
1	Visceral Leishmaniasis (Kala Azar) 09/2015
1	Leishmaniasis 09/2015
1	Foot-and-Mouth Disease 11/2014
1	Classical Swine Fever (Swine Fever) 10/2014
1	Lung Neoplasms (Lung Cancer) 10/2013
1	Fever (Fevers) 04/2013
1	Body Weight (Weight, Body) 01/2012
1	Persistent Infection 07/2011
1	Viremia 07/2009

Drug/Important Bio-Agent (IBA)

16	VaccinesIBA 06/2022 - 02/2013
8	CytokinesIBA 01/2021 - 07/2009
6	AerosolsIBA 08/2021 - 01/2012
4	EnzymesIBA 01/2020 - 04/2013
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 10/2006
4	Prion ProteinsIBA 11/2006 - 05/2004
3	Interleukin-10 (Interleukin 10)IBA 10/2015 - 07/2009
3	Interferon-gamma (Interferon, gamma)IBA 10/2014 - 07/2009
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
2	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2022 - 01/2018
2	Monoclonal AntibodiesIBA 01/2021 - 01/2006
2	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2018
2	DNA VaccinesIBA 01/2021 - 09/2015
2	Interferon Type IIBA 01/2021 - 10/2014
2	Biological ProductsIBA 08/2019 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 03/2017 - 07/2011
2	CollagenIBA 10/2015 - 07/2011
1	Subgenomic RNAIBA 01/2022
1	Single-Domain AntibodiesIBA 01/2021
1	ChAdOx1 nCoV-19IBA 01/2021
1	EpitopesIBA 01/2021
1	reluscovtogene ralaplasmidIBA 01/2021
1	Immune Sera (Antisera)IBA 01/2021
1	AcidsIBA 12/2020
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 10/2020
1	Immunoglobulin A (IgA)IBA 11/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2019
1	InterferonsIBA 01/2019
1	AntigensIBA 01/2019
1	Caspase 3 (Caspase-3)IBA 01/2019
1	Tuberculin (PPD)IBA 01/2018
1	imidazoloneIBA 01/2018
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2018
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2018
1	ImmunosorbentsIBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Pyruvaldehyde (Methylglyoxal)IBA 01/2018
1	Advanced Glycation End ProductsIBA 01/2018
1	Neutralizing AntibodiesIBA 01/2018
1	LipidsIBA 01/2017
1	Metalloproteases (Metalloproteinases)IBA 10/2015
1	Pharmaceutical PreparationsIBA 09/2015
1	Immunologic Factors (Immunomodulators)IBA 09/2015
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 09/2015
1	liposomal amphotericin B FDA Link 09/2015
1	Attenuated VaccinesIBA 04/2015
1	PerforinIBA 10/2014
1	3,4-methylenedioxyethamphetamine (MDEA)IBA 10/2013
1	Virus ReceptorsIBA 02/2013
1	HaptoglobinsIBA 02/2013
1	Interferon Receptors (Interferon Receptor)IBA 01/2012
1	RestonIBA 01/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2011
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 07/2011
1	Interferon-alpha (Interferon Alfa)IBA 07/2009
1	Interleukin-12 (IL 12)IBA 07/2009
1	PrebioticsIBA 01/2009
1	AntibodiesIBA 10/2006

Therapy/Procedure

7	Therapeutics 06/2022 - 04/2013
1	Intranasal Administration 01/2021
1	Aftercare (After-Treatment) 01/2019
1	Immunotherapy 09/2015